Bench to Bedside and Back Again: Molecular Mechanisms of Alpha-catenin Function and Roles in Tumorigenesis

Overview

Journal Semin Cancer Biol

Specialty Oncology

Date 2007 Oct 20

PMID 17945508

Citations 67

Authors

Jacqueline M Benjamin

W James Nelson

Affiliations

Soon will be listed here.

Abstract

The cadherin/catenin complex, comprised of E-cadherin, beta-catenin and alpha-catenin, is essential for initiating cell-cell adhesion, establishing cellular polarity and maintaining tissue organization. Disruption or loss of the cadherin/catenin complex is common in cancer. As the primary cell-cell adhesion protein in epithelial cells, E-cadherin has long been studied in cancer progression. Similarly, additional roles for beta-catenin in the Wnt signaling pathway has led to many studies of the role of beta-catenin in cancer. Alpha-catenin, in contrast, has received less attention. However, recent data demonstrate novel functions for alpha-catenin in regulating the actin cytoskeleton and cell-cell adhesion, which when perturbed could contribute to cancer progression. In this review, we use cancer data to evaluate molecular models of alpha-catenin function, from the canonical role of alpha-catenin in cell-cell adhesion to non-canonical roles identified following conditional alpha-catenin deletion. This analysis identifies alpha-catenin as a prognostic factor in cancer progression.

Citing Articles

Multiscale mechanical-adapted hydrogels for the repair of intervertebral disc degeneration.

Cai W, Yang F, Yang C, Liu Y, Xu H, Zhang W Bioact Mater. 2025; 48:336-352.

PMID: 40060142 PMC: 11889691. DOI: 10.1016/j.bioactmat.2025.02.021.

Current advances and challenges in Managing Hereditary Diffuse Gastric Cancer (HDGC): a narrative review.

van der Sluis L, van Dieren J, van der Post R, Bisseling T Hered Cancer Clin Pract. 2024; 22(1):21.

PMID: 39379994 PMC: 11462652. DOI: 10.1186/s13053-024-00293-5.

The redefines the apical junction of intestinal epithelia.

Mangeol P, Massey-Harroche D, Sebbagh M, Richard F, Le Bivic A, Lenne P Proc Natl Acad Sci U S A. 2024; 121(9):e2316722121.

PMID: 38377188 PMC: 10907237. DOI: 10.1073/pnas.2316722121.

Anoikis resistance--protagonists of breast cancer cells survive and metastasize after ECM detachment.

Dai Y, Zhang X, Ou Y, Zou L, Zhang D, Yang Q Cell Commun Signal. 2023; 21(1):190.

PMID: 37537585 PMC: 10399053. DOI: 10.1186/s12964-023-01183-4.

α-catenin interaction with YAP/FoxM1/TEAD-induced CEP55 supports liver cancer cell migration.

Tang Y, Thiess L, Weiler S, Toth M, Rose F, Merker S Cell Commun Signal. 2023; 21(1):162.

PMID: 37381005 PMC: 10304383. DOI: 10.1186/s12964-023-01169-2.

References

Giannini A, Vivanco M, Kypta R . alpha-catenin inhibits beta-catenin signaling by preventing formation of a beta-catenin*T-cell factor*DNA complex. J Biol Chem. 2000; 275(29):21883-8. DOI: 10.1074/jbc.M001929200. View

Fujimoto J, Ichigo S, Hirose R, Sakaguchi H, Tamaya T . Expression of E-cadherin and alpha- and beta-catenin mRNAs in uterine cervical cancers. Tumour Biol. 1997; 18(4):206-12. DOI: 10.1159/000218033. View

Tanaka N, Odajima T, Ogi K, Ikeda T, Satoh M . Expression of E-cadherin, alpha-catenin, and beta-catenin in the process of lymph node metastasis in oral squamous cell carcinoma. Br J Cancer. 2003; 89(3):557-63. PMC: 2394393. DOI: 10.1038/sj.bjc.6601124. View

Ikeguchi M, Makino M, Kaibara N . Clinical significance of E-cadherin-catenin complex expression in metastatic foci of colorectal carcinoma. J Surg Oncol. 2001; 77(3):201-7. DOI: 10.1002/jso.1095. View

Davidson B, Berner A, Nesland J, Risberg B, Berner H, Trope C . E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions. J Pathol. 2000; 192(4):460-9. DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH726>3.0.CO;2-M. View

Fujimoto J, Ichigo S, Hori M, Tamaya T . Expressions of E-cadherin and alpha- and beta-catenin mRNAs in uterine endometrial cancers. Eur J Gynaecol Oncol. 1998; 19(1):78-81. View

Robles-Frias A, Gonzalez-Campora R, Martinez-Parra D, Robles-Frias M, Vazquez-Cerezuela T, Otal-Salaverri C . Robinson cytologic grading in invasive ductal carcinoma of the breast: correlation with E-cadherin and alpha-, beta- and gamma-catenin expression and regional lymph node metastasis. Acta Cytol. 2006; 50(2):151-7. DOI: 10.1159/000325924. View

Vestweber D, Kemler R . Identification of a putative cell adhesion domain of uvomorulin. EMBO J. 1985; 4(13A):3393-8. PMC: 554675. DOI: 10.1002/j.1460-2075.1985.tb04095.x. View

Ghadimi B, Behrens J, Hoffmann I, Haensch W, Birchmeier W, Schlag P . Immunohistological analysis of E-cadherin, alpha-, beta- and gamma-catenin expression in colorectal cancer: implications for cell adhesion and signaling. Eur J Cancer. 1999; 35(1):60-5. DOI: 10.1016/s0959-8049(98)00344-x. View

10.

Koksal I, Ates M, Danisman A, Sezer C, Ciftcioglu A, Karpuzoglu G . Reduced E-cadherin and alpha-catenin expressions have no prognostic role in bladder carcinoma. Pathol Oncol Res. 2006; 12(1):13-9. DOI: 10.1007/BF02893426. View

11.

Shimazui T, Schalken J, Giroldi L, Jansen C, Akaza H, Koiso K . Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors. Cancer Res. 1996; 56(18):4154-8. View

12.

Naka T, Oda Y, Iwamoto Y, Shinohara N, Chuman H, Fukui M . Immunohistochemical analysis of E-cadherin, alpha-catenin, beta-catenin, gamma-catenin, and neural cell adhesion molecule (NCAM) in chordoma. J Clin Pathol. 2001; 54(12):945-50. PMC: 1731331. DOI: 10.1136/jcp.54.12.945. View

13.

Kooy A, Tank B, de Jong A, Vuzevski V, van der Kwast T, van Joost T . Expression of E-cadherin, alpha- & beta-catenin, and CD44V6 and the subcellular localization of E-cadherin and CD44V6 in normal epidermis and basal cell carcinoma. Hum Pathol. 1999; 30(11):1328-35. DOI: 10.1016/s0046-8177(99)90064-3. View

14.

Weis W, Nelson W . Re-solving the cadherin-catenin-actin conundrum. J Biol Chem. 2006; 281(47):35593-7. PMC: 3368706. DOI: 10.1074/jbc.R600027200. View

15.

Toyoyama H, Nuruki K, Ogawa H, Yanagi M, Matsumoto H, Nishijima H . The reduced expression of e-cadherin, alpha-catenin and gamma-catenin but not beta-catenin in human lung cancer. Oncol Rep. 1998; 6(1):81-5. DOI: 10.3892/or.6.1.81. View

16.

Hao X, Palazzo J, Ilyas M, Tomlinson I, Talbot I . Reduced expression of molecules of the cadherin/catenin complex in the transition from colorectal adenoma to carcinoma. Anticancer Res. 1997; 17(3C):2241-7. View

17.

Kim Y, Choi E, Kim J, Kim D, Kim S, Yang W . Expression of E-cadherin and alpha-, beta-, gamma-catenin proteins in endometrial carcinoma. Yonsei Med J. 2002; 43(6):701-11. DOI: 10.3349/ymj.2002.43.6.701. View

18.

Richmond P, Karayiannakis A, Nagafuchi A, Kaisary A, Pignatelli M . Aberrant E-cadherin and alpha-catenin expression in prostate cancer: correlation with patient survival. Cancer Res. 1997; 57(15):3189-93. View

19.

Taniguchi T, Miyazaki M, Miyashita Y, Arima T, Ozawa M . Identification of regions of alpha-catenin required for desmosome organization in epithelial cells. Int J Mol Med. 2005; 16(6):1003-8. View

20.

Ihara A, Koizumi H, Hashizume R, Uchikoshi T . Expression of epithelial cadherin and alpha- and beta-catenins in nontumoral livers and hepatocellular carcinomas. Hepatology. 1996; 23(6):1441-7. DOI: 10.1053/jhep.1996.v23.pm0008675162. View